Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
First-episode psychosis refers to individuals early in the course of psychotic illness. Identifying the underlying biological processes, including biomarkers, is essential for improving diagnosis and treatment. We performed metabolomics profiling of plasma from a group of first-episode psychosis pat...
Enregistré dans:
Auteurs principaux: | Bracha Erlanger Avigdor, Kun Yang, Ida Shinder, Benjamin C. Orsburn, Rana Rais, Shin-ichi Kano, Akira Sawa, Jonathan Pevsner |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8ab035f50f2047a1b33dcff5dbfc1af7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021) -
Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
par: Lei Chen, et autres
Publié: (2021) -
Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
par: Huang YC, et autres
Publié: (2018) -
Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
par: Leonid Mikhaylovich Bardenshteyn, et autres
Publié: (2010) -
Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
par: Pu C, et autres
Publié: (2020)